Transactions with related parties (Details) - Veraxa Biotech A G [Member] - CHF (SFr) |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Entity Information [Line Items] | ||
| Other receivables - Xlife | SFr 45,789 | |
| Other receivables - related party (Veraxa Biotech Holding AG) | 8,856 | |
| Notes payable - Xlife | 1,000,000 | |
| Prepaid benefit receipt | SFr 4,369 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The amount of current interest payable. [Refer: Interest payable] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of current prepayments. [Refer: Prepayments] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount receivable by the entity that it does not separately disclose in the same statement or note. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|